The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis

Background: Migraine is the most common acute primary headache in children and adolescents. In 2014, topiramate became the first preventive drug for migraine, approved by the Food and Drug Administration (FDA) for adolescents. This meta-analysis was aimed to evaluate the efficacy and safety of topir...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xinwei, Zhang, Yan, Lu, Mei, Yu, Xiaolin, Ye, Xiang, Wang, Xingbang, Shan, Peiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056737/
https://www.ncbi.nlm.nih.gov/pubmed/32175291
http://dx.doi.org/10.3389/fped.2020.00028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056737/
https://www.ncbi.nlm.nih.gov/pubmed/32175291
http://dx.doi.org/10.3389/fped.2020.00028

Ejemplares similares